Is KURA a good investment?
As of 2025-03-25, the Fair Value of Kura Oncology Inc (KURA) is -10.10 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 7.65 USD, the upside of Kura Oncology Inc is -231.98%. This means that KURA is not a good investment.
Note: valuation result may not be accurate due to the low predictability of business.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -89.63 | -130.47 | -135.84 | -152.63 | -173.98 | -136.51 |
| YoY growth | -41.95% | -45.57% | -4.12% | -12.36% | -13.99% | -23.60% |
| Market Cap (mil) | 617.74 |
| P/E | |
| Forward P/E |
| EPS | -2.02 |
| Avg earnings growth rate | -23.60% |
| TTM earnings |